Literature DB >> 8508299

Cell loss in supraoptic and paraventricular nucleus in Alzheimer's disease.

S de Lacalle1, I Iraizoz, L M Gonzalo.   

Abstract

Previous studies have shown an activation of the hypothalamo-neurohypophyseal system (HNS) in normal aging and in senile dementia. Among other explanations, this activation might be secondary to cell loss in the supraoptic (SO) and paraventricular (PV) nuclei. This study reports a 63% loss in the SO and a 56% loss in the PV in a group of Alzheimer disease (AD) patients. The remaining neurons undergo a compensatory hypertrophy that is more pronounced in the SO, affecting cell and nuclear size as well as nucleolar volume. The group of patients with a diagnosis of moderate dementia showed the greatest hypertrophy, as compared to the severely demented patients. Our results suggest that there is a compensatory capacity in the earlier stages of the dementia, that is lost in the final stages of Alzheimer's disease.

Entities:  

Mesh:

Year:  1993        PMID: 8508299     DOI: 10.1016/0006-8993(93)90868-n

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.

Authors:  Miguel Angel Riudavets; Diego Iacono; Susan M Resnick; Richard O'Brien; Alan B Zonderman; Lee J Martin; Gay Rudow; Olga Pletnikova; Juan C Troncoso
Journal:  Neurobiol Aging       Date:  2007-06-28       Impact factor: 4.673

2.  Reduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer's disease.

Authors:  Natalia Loskutova; Robyn A Honea; William M Brooks; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood.

Authors:  Roy Lardenoije; Janou A Y Roubroeks; Ehsan Pishva; Markus Leber; Holger Wagner; Artemis Iatrou; Adam R Smith; Rebecca G Smith; Lars M T Eijssen; Luca Kleineidam; Amit Kawalia; Per Hoffmann; Tobias Luck; Steffi Riedel-Heller; Frank Jessen; Wolfgang Maier; Michael Wagner; René Hurlemann; Gunter Kenis; Muhammad Ali; Antonio Del Sol; Diego Mastroeni; Elaine Delvaux; Paul D Coleman; Jonathan Mill; Bart P F Rutten; Katie Lunnon; Alfredo Ramirez; Daniël L A van den Hove
Journal:  Clin Epigenetics       Date:  2019-11-27       Impact factor: 6.551

4.  Frontal Lobe Function and Risk of Hip Fracture in Patient With Alzheimer Disease: An Analysis of Linked Data.

Authors:  Hyun Woong Roh; Chang Hyung Hong; SooJin Lee; Yunhwan Lee; Kang Soo Lee; Ki Jung Chang; Byoung Hoon Oh; Seong Hye Choi; Seong Yoon Kim; Joung Hwan Back; Young Ki Chung; Ki Young Lim; Jai Sung Noh; Sang Joon Son
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.